Caledonia rustles up IPOs, asset sales, takeover targets in busy quarter

Key highlights from Caledonia’s June quarter update, where the fund manager discussed its high-conviction stock picks such as Just Eat Takeaway.com and Genius Sports, plus how the company is taking advantage of initial public offering opportunities on the horizon.
Caledonia (Private) Investments’ Will Vicars. Picture: Sahlan Hayes

Anthony Macdonald and Yolanda Redrup

Caledonia rustles up IPOs, asset sales, takeover targets in busy quarter

August 1, 2021
Key highlights from Caledonia’s June quarter update, where the fund manager discussed its high-conviction stock picks such as Just Eat Takeaway.com and Genius Sports, plus how the company is taking advantage of initial public offering opportunities on the horizon.
Read Transcript

Sydney fund manager Caledonia (Private) Investments is doing its bit for Australia’s dealmaking set - and not just the stockbrokers busily trading its high conviction bets.

In its June quarter update, chief investment officers Will Vicars and Mike Messara outlined the firm’s role in a heavy corporate activity schedule, with deals surrounding a bunch of its high conviction stockpicks and highlighting more to come.

In Australia, it tipped longstanding investment Challenger Ltd into the crosshairs of life insurer/retirement services group Athene and Apollo Global Management, selling its long-held 15 per cent stake at a 10 per cent premium to the market price.

“This was a hard decision, as many of the key tenets that underpinned our investment thesis remain in tact. However, changes to the distribution model and increase capital intensity have reduced our expectations for earnings growth,” the investors told clients over the weekend.

Vicars and Messara said the fact a strategic party was willing to pay a 10 per cent premium to take the stake validated its conviction that large, concentrated holdings were of value - even when seeking to exit.

 Caledonia’s also behind US gaming group Scientific Games, which has called in the bankers to help assess a $5 billion-plus Australian IPO for its global lotteries business.

Caledonia backed SciGames last year, as part of a deal that also saw former Aristocrat Leisure executives Jamie Odell and Toni Korsanos take the reins and try to turn around the debt-laden gaming company. The pair’s strategic review has its lotteries and OpenBet business up for grabs.

“These are terrific assets and we are very excited to see the outcome here,” Caledonia’s pair said.

Then there was Grubhub’s long-anticipated merger with Just Eat Takeaway, which is trading under the latter’s name, and another gaming group, Flutter, where Caledonia is tipping an IPO for its American sports betting business FanDuel next year.

 

Genius pick

And as for this year’s IPOs, Caledonia explained why it took a stake in Genius Sports, a $US3.3 billion sports data and technology company that listed in April.

It was the kind of thesis for which Caledonia is renowned - big addressable market, a new industry and the chance to emerge as the No.1 player - that will have its wealthy family backers mulling direct investments into Genius Sports. It says sports data is the “picks and shovels” for bookies, at a time when bookies are scrambling to offer in-play bets.

Caledonia also flagged some more internal huffling; it’s putting more of its Flutter shares into its co-investment fund, soon after doing the same with Zillow.

As always, a fundie lives and dies by its numbers.

Caledonia told investors it returned 18.2 per in the year to June 30, which was about half the MSCI World Index at 37.5 per cent. That’s another byproduct of large, concentrated holdings; Caledonia’s hits and misses are rarely boring. It was also indicative of a tough year for short-sellers.

Caledonia reminded investors that it had returned 18.9 per cent a year since inception (or since 2012 at least, when it turned into long/short manager), on a compound annual growth rate basis.

 

 

This article was originally posted on The Australian Financial Review here.

Licensed by Copyright Agency. You must not copy this work without permission.

 

Sydney fund manager Caledonia (Private) Investments is doing its bit for Australia’s dealmaking set - and not just the stockbrokers busily trading its high conviction bets.

In its June quarter update, chief investment officers Will Vicars and Mike Messara outlined the firm’s role in a heavy corporate activity schedule, with deals surrounding a bunch of its high conviction stockpicks and highlighting more to come.

In Australia, it tipped longstanding investment Challenger Ltd into the crosshairs of life insurer/retirement services group Athene and Apollo Global Management, selling its long-held 15 per cent stake at a 10 per cent premium to the market price.

“This was a hard decision, as many of the key tenets that underpinned our investment thesis remain in tact. However, changes to the distribution model and increase capital intensity have reduced our expectations for earnings growth,” the investors told clients over the weekend.

Vicars and Messara said the fact a strategic party was willing to pay a 10 per cent premium to take the stake validated its conviction that large, concentrated holdings were of value - even when seeking to exit.

 Caledonia’s also behind US gaming group Scientific Games, which has called in the bankers to help assess a $5 billion-plus Australian IPO for its global lotteries business.

Caledonia backed SciGames last year, as part of a deal that also saw former Aristocrat Leisure executives Jamie Odell and Toni Korsanos take the reins and try to turn around the debt-laden gaming company. The pair’s strategic review has its lotteries and OpenBet business up for grabs.

“These are terrific assets and we are very excited to see the outcome here,” Caledonia’s pair said.

Then there was Grubhub’s long-anticipated merger with Just Eat Takeaway, which is trading under the latter’s name, and another gaming group, Flutter, where Caledonia is tipping an IPO for its American sports betting business FanDuel next year.

 

Genius pick

And as for this year’s IPOs, Caledonia explained why it took a stake in Genius Sports, a $US3.3 billion sports data and technology company that listed in April.

It was the kind of thesis for which Caledonia is renowned - big addressable market, a new industry and the chance to emerge as the No.1 player - that will have its wealthy family backers mulling direct investments into Genius Sports. It says sports data is the “picks and shovels” for bookies, at a time when bookies are scrambling to offer in-play bets.

Caledonia also flagged some more internal huffling; it’s putting more of its Flutter shares into its co-investment fund, soon after doing the same with Zillow.

As always, a fundie lives and dies by its numbers.

Caledonia told investors it returned 18.2 per in the year to June 30, which was about half the MSCI World Index at 37.5 per cent. That’s another byproduct of large, concentrated holdings; Caledonia’s hits and misses are rarely boring. It was also indicative of a tough year for short-sellers.

Caledonia reminded investors that it had returned 18.9 per cent a year since inception (or since 2012 at least, when it turned into long/short manager), on a compound annual growth rate basis.

 

 

This article was originally posted on The Australian Financial Review here.

Licensed by Copyright Agency. You must not copy this work without permission.

 

Disclaimer: This material has been prepared by Australian Financial Review, published on Aug 01, 2021. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
No items found.
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lancaster sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.